Pulmonary hypertension in children with hemolytic disorders
- 14 January 2020
- journal article
- review article
- Published by Elsevier BV in Progress in Pediatric Cardiology
- Vol. 56, 101194
- https://doi.org/10.1016/j.ppedcard.2020.101194
Abstract
No abstract availableKeywords
This publication has 106 references indexed in Scilit:
- Mortality in Adults With Sickle Cell Disease and Pulmonary HypertensionJAMA, 2012
- Advances in pediatric pulmonary arterial hypertensionCurrent Opinion in Cardiology, 2012
- The critical roles of platelet activation and reduced NO bioavailability in fatal pulmonary arterial hypertension in a murine hemolysis modelBlood, 2010
- Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studiesBritish Journal of Haematology, 2010
- Relationship of erythropoietin, fetal hemoglobin, and hydroxyurea treatment to tricuspid regurgitation velocity in children with sickle cell diseaseBlood, 2009
- Endothelin receptor antagonists for pulmonary hypertension in adult patients with sickle cell diseaseBritish Journal of Haematology, 2009
- Improvement in hemolysis and pulmonary arterial systolic pressure in adult patients with sickle cell disease during treatment with hydroxyureaAmerican Journal of Hematology, 2009
- Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobinBlood, 2007
- PULMONARY HYPERTENSION IN SICKLE CELL DISEASE: Relevance to ChildrenPediatric Hematology and Oncology, 2007
- Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailabilityBlood, 2006